Tetrahydroquinoline/4,5-dihydroisoxazoline derivatives counteract multidrug resistance in cancer cells by inhibiting P-glycoprotein (ABCB1)-mediated transport.
Hembecker M, Kita DH, Rashidian A, Vesga LC, Ruginsk BE, Bohórquez ARR, Mendez-Sanchez SC, Maltarollo VG, Rego FGM, Picheth G, Poso A, Goda K, Ambudkar SV, Moure VR, Kronenberger T, Valdameri G.
Hembecker M, et al. Among authors: valdameri g.
Biochim Biophys Acta Gen Subj. 2026 Feb;1870(2):130894. doi: 10.1016/j.bbagen.2025.130894. Epub 2025 Dec 4.
Biochim Biophys Acta Gen Subj. 2026.
PMID: 41352692